Bank of New York Mellon
PAND

Bank of New York Mellon’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Bank of New York Mellon’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27,751
Closed -$1.67M – 4555
2021
Q1 		$1.67M Buy
27,751
+10,651
+62% +$386K ﹤0.01% 3031
2020
Q4 		$254K Buy
17,100
+3,409
+25% +$47.4K ﹤0.01% 3891
2020
Q3 		$157K Buy
+13,691
New +$234K ﹤0.01% 3899

Bank of New York Mellon's PAND Position: Q2 2021 in Review

Bank of New York Mellon sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 27,751 shares — an estimated $1.67M sold.

Bank of New York Mellon first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $1.67M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Bank of New York Mellon reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 27,751 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $1.67M.
  • Bank of New York Mellon first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Bank of New York Mellon's Pandion Therapeutics Inc. Common Stock position peaked at $1.67M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.